Mobile Menu - OpenMobile Menu - Closed


Health Care


In the 113th Congressman Bilirakis joined the Energy and Commerce Committee. Part of his Committee assignment includes serving on the Health Subcommittee, with jurisdiction over Medicare, Medicaid, the Affordable Care Act – better known as Obamacare – and the rest of the American health care system.

Congressman Bilirakis has introduced two pieces of legislation to help preserve Medicare for current and future beneficiaries. H.R. 3392, the Medicare Part D Patient Safety and Drug Abuse Prevention Act, would establish a Safe Pharmacy Access Program, to prevent high-risk beneficiaries from abusing controlled substances. This is a cost-saving measure utilized by private industry, TRICARE, and state Medicaid programs. H.R. 2828, the Medicare Abuse Prevention (MAP) Act, would remove Social Security Numbers from Medicare cards and strengthens the civil and criminal penalties for Medicare, Medicaid, and CHIP abuse. It would also incentivize states to conduct their own prescription drug monitoring programs.

Bilirakis is a staunch opponent of Obamacare. He opposed the legislation when it passed in 2009, and has worked to repeal and replace the law. Bilirakis supports the infusion of free market principles and cost transparency into the health care system, which he believes is the best way to lower costs and increase access to affordable care. He opposed a government takeover of health care, and has long been an advocate for Health Savings Accounts, access to catastrophic care, and high risk pools to ensure coverage for individuals with pre-existing conditions.

Bilirakis supports legislation to allow veterans who completed military emergency medical technician (EMT) training to more easily receive civilian accreditation to work as EMTs; to create a 10-Year Pediatric Research Initiative Fund to the National Institutes of Health; and to allow epi-pens to be kept in schools. In the past, Bilirakis has sponsored legislation to require Medicare to cover hearing aids for older Americans to improve their quality of life and increase their safety. Gus also has voted to renew important breast and cervical cancer detection programs.

Additionally, Congressman Bilirakis is a member of numerous health care-related caucuses through which he advocates for many important causes, including the:

  • Community Health Center Caucus
  • Brain Injury Task Force
  • Health Care Caucus;
  • Prescription Drug Caucus;
  • Congenital Heart Caucus;
  • Cystic Fibrosis Caucus;
  • Diabetes Caucus;
  • Down Syndrome Caucus;
  • Health Hearing Caucus;
  • Vision Caucus;
  • House Cancer Caucus; and
  • Pediatric Cancer Caucus.

More on Health Care

June 30, 2020 Press Release

Today, the Health Subcommittee reviewed a variety of bills designed to help prevent suicide and improve access to mental health treatment.  Congressman Gus Bilirakis, a long-standing champion of mental health reform, is the co-author of three of these bipartisan measures.  The Effective Suicide Screening in the Emergency Department Act helps to create protocols for identifying, assessing and treating individuals in the E.R. who may be at risk for suicide.

January 16, 2020 Bilirakis Blog

Letter to National Institute of Health's Dr. Collins re oversight.

PDF iconLtr to NIH re Oversight.pdf

January 3, 2020 Press Release

PRESS RELEASE:  January 3, 2020
CONTACT:  Summer Robertson  727-232-2921

Bilirakis Bill to Ensure Patients in Need of Bone Marrow and Stem Cell Transplant Have Access to Lifesaving Treatment is Signed Into Law

August 15, 2017 Press Release

New Port Richey, FL – U.S. Rep. Gus Bilirakis (FL-12) announced today he will be joining the Alzheimer’s Association to host an Alzheimer’s Summit for patients, family members, caregivers, medical professionals, and more in New Port Richey, Florida. The event will provide resources for better understanding Alzheimer’s and will include a presentation on current research on the disease.

July 18, 2017 Press Release
U.S. Reps. Gus Bilirakis (FL-12) and Kathy Castor (FL-14) announced today that they introduced the bipartisan Medicare Civil and Criminal Penalties Update Act, H.R. 3245.
July 12, 2017 Press Release
U.S. Rep. Gus Bilirakis released the following statement after today’s unanimous, bipartisan House passage of the Food and Drug Administration (FDA) Reauthorization Act, H.R. 2430.
July 12, 2017 Press Release
During a congressional hearing on combatting the nation’s opioid crisis, U.S. Rep. Gus Bilirakis (FL-12) questioned officials from four states about what initiatives are working to help curb the epidemic, and what needs improvement.
July 11, 2017 Press Release
Ahead of an important vote in the House of Representatives to reform the Food and Drug Administration, a recent University of Florida study found that the rise in cost of generic prescription drugs may be due to a lack of market competition. U.S. Rep. Gus Bilirakis (FL-12) has a bipartisan provision in the FDA Reauthorization Act (H.R. 2430) to spur the development of new generic drugs and help combat high drug prices.
June 29, 2017 Press Release
In honor of National Post-Traumatic Stress (PTS) Awareness Month, U.S. Rep. Gus Bilirakis (FL-12) took to the U.S. House floor to break the stigma surrounding PTS.
June 21, 2017 Press Release

Washington, D.C. – U.S. Representative Gus Bilirakis (FL-12) and Senator Marco Rubio (FL) announced today they are leading efforts to help ensure Florida’s Children’s Health Insurance Program (CHIP) continues providing quality, affordable insurance to children across the state. Bilirakis and Rubio sent a letter to U.S. Health & Human Services Secretary Tom Price urging him to take action on much-needed regulatory changes to allow the program to better serve Florida children and their families.